東珠生態(603359.SH):第二季度新簽訂項目合同金額5.39億元
格隆匯 7 月 29日丨東珠生態(603359.SH)公佈,2020年4月至6月,公司及子公司新中標項目3項,金額約人民幣5.42億元。新中標項目中,園林綠化生態工程施工業務2項,規劃設計業務1項。
2020年4月至6月,公司及子公司新簽訂項目合同2項,合計項目金額為人民幣5.39億元。新簽訂項目合同中,園林綠化生態工程施工業務合同2項。
2020年至今,公司及子公司累計新中標項目8項,合計金額為人民幣8.61億元。新中標項目中,園林綠化生態工程施工業務7項,規劃設計業務1項。
2020年至今,公司及子公司累計新簽訂項目合同9項,合計金額為人民幣9.02億元。新簽訂項目合同中,園林綠化生態工程施工業務合同8項,規劃設計業務合同1項。
上述合同均在執行中,公司未發生影響業績的重大事項,公司主營業務的各項經營活動一切正常。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.